Skip to main content

Table 7 High impact mutations in cancer driver genes in the Oncopig hepatocellular carcinoma model

From: Development of a whole-exome sequencing kit to facilitate porcine biomedical research

Gene

Mutated amino acid

Number of amino acids in gene

VAF in Oncopig HCC cell line

VAF in Oncopig HCC tumor

Pathways relevant to HCC enriched for variants

CASP8

p.Glu89*

486

N/A

0.036

Molecular mechanisms of cancer

MYC mediated apoptosis signaling

EZR

p.Gln322*

562

N/A

0.034

Actin cytoskeleton signaling

MAP3K1

p.Glu865*

1508

N/A

0.029

Regulation of the epithelial mesenchymal transition by growth factors

Integrin signaling

EGF signaling

PDGF signaling

UBR5

p.Gly1240*

2705

N/A

0.036

0.010

N/A

PRPF40B

p.Ser244*

980

N/A

0.016

0.010

Spliceosomal cycle

BCL9

p.Arg667*

1426

0.010

0.047

Regulation of the epithelial-mesenchymal transition

WNT/B-catenin signaling

PDGFRA

p.Trp878*

1088

N/A

0.022

Hepatic fibrosis signaling/stellate cell activation

PTEN signaling

PDGF signaling

SETDB1

p.Glu115*

1332

N/A

0.036

N/A

TCF7L2

p.Cys534fs

669

0.133

0.094

0.026

0.024

Hepatic fibrosis signaling

Epithelial adherens junction signaling

Regulation of the epithelial-mesenchymal transition

WNT/B-catenin signaling

GRM3

p.Gln408*

879

N/A

0.016

N/A

  1. HCC hepatocellular carcinoma, VAF variant allele frequency
  2. p.#* indicates presence of premature stop codon at a particular amino acid